Literature DB >> 19298246

Oligoclonal TRBV gene usage among CD8(+) T cells in monoclonal B lymphocytosis and CLL.

Mark C Lanasa1, Sallie D Allgood, Karen M Bond, Jon P Gockerman, Marc C Levesque, J Brice Weinberg.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19298246      PMCID: PMC2754701          DOI: 10.1111/j.1365-2141.2009.07635.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  11 in total

1.  Oligoclonal TCRBV gene usage in B-cell chronic lymphocytic leukemia: major perturbations are preferentially seen within the CD4 T-cell subset.

Authors:  M R Rezvany; M Jeddi-Tehrani; A Osterborg; E Kimby; H Wigzell; H Mellstedt
Journal:  Blood       Date:  1999-08-01       Impact factor: 22.113

2.  Expansions of clonal and oligoclonal T cells in B-cell chronic lymphocytic leukemia are primarily restricted to the CD3(+)CD8(+) T-cell population.

Authors:  C L Goolsby; M Kuchnio; W G Finn; L Peterson
Journal:  Cytometry       Date:  2000-06-15

Review 3.  The indispensable role of microenvironment in the natural history of low-grade B-cell neoplasms.

Authors:  P Ghia; F Caligaris-Cappio
Journal:  Adv Cancer Res       Date:  2000       Impact factor: 6.242

4.  Monoclonal CD5+ and CD5- B-lymphocyte expansions are frequent in the peripheral blood of the elderly.

Authors:  Paolo Ghia; Giuseppina Prato; Cristina Scielzo; Stefania Stella; Massimo Geuna; Giuseppe Guida; Federico Caligaris-Cappio
Journal:  Blood       Date:  2003-11-20       Impact factor: 22.113

5.  Statistical analysis of antigen receptor spectratype data.

Authors:  Thomas B Kepler; Min He; John K Tomfohr; Blythe H Devlin; Marcella Sarzotti; M Louise Markert
Journal:  Bioinformatics       Date:  2005-06-14       Impact factor: 6.937

6.  Prognostic importance of T and NK-cells in a consecutive series of newly diagnosed patients with chronic lymphocytic leukaemia.

Authors:  Shanique Palmer; Curtis A Hanson; Clive S Zent; Luis F Porrata; Betsy Laplant; Susan M Geyer; Svetomir N Markovic; Timothy G Call; Deborah A Bowen; Diane F Jelinek; Neil E Kay; Tait D Shanafelt
Journal:  Br J Haematol       Date:  2008-04-01       Impact factor: 6.998

7.  Monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia.

Authors:  Andy C Rawstron; Fiona L Bennett; Sheila J M O'Connor; Marwan Kwok; James A L Fenton; Marieth Plummer; Ruth de Tute; Roger G Owen; Stephen J Richards; Andrew S Jack; Peter Hillmen
Journal:  N Engl J Med       Date:  2008-08-07       Impact factor: 91.245

8.  Monoclonal B lymphocytes with the characteristics of "indolent" chronic lymphocytic leukemia are present in 3.5% of adults with normal blood counts.

Authors:  Andy C Rawstron; Michael J Green; Anita Kuzmicki; Ben Kennedy; James A L Fenton; Paul A S Evans; Sheila J M O'Connor; Stephen J Richards; Gareth J Morgan; Andrew S Jack; Peter Hillmen
Journal:  Blood       Date:  2002-07-15       Impact factor: 22.113

9.  Clinical and molecular predictors of disease severity and survival in chronic lymphocytic leukemia.

Authors:  J Brice Weinberg; Alicia D Volkheimer; Youwei Chen; Bethany E Beasley; Ning Jiang; Mark C Lanasa; Daphne Friedman; Gina Vaccaro; Catherine W Rehder; Carlos M Decastro; David A Rizzieri; Louis F Diehl; Jon P Gockerman; Joseph O Moore; Barbara K Goodman; Marc C Levesque
Journal:  Am J Hematol       Date:  2007-12       Impact factor: 10.047

10.  Leukemia-associated monoclonal and oligoclonal TCR-BV use in patients with B-cell chronic lymphocytic leukemia.

Authors:  Mohammad-Reza Rezvany; Mahmood Jeddi-Tehrani; Hans Wigzell; Anders Osterborg; Håkan Mellstedt
Journal:  Blood       Date:  2002-10-03       Impact factor: 22.113

View more
  2 in total

Review 1.  Immunologic aspects of monoclonal B-cell lymphocytosis.

Authors:  Mark C Lanasa; J Brice Weinberg
Journal:  Immunol Res       Date:  2011-04       Impact factor: 2.829

Review 2.  Immune Dysfunctions and Immune-Based Therapeutic Interventions in Chronic Lymphocytic Leukemia.

Authors:  Valentina Griggio; Francesca Perutelli; Chiara Salvetti; Elia Boccellato; Mario Boccadoro; Candida Vitale; Marta Coscia
Journal:  Front Immunol       Date:  2020-11-18       Impact factor: 7.561

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.